Serina Therapeutics, Inc. (SER)
2.105
-0.14
(-6.44%)
USD |
NYAM |
Sep 21, 16:00
2.105
0.00 (0.00%)
After-Hours: 20:00
Serina Therapeutics Market Cap : 53.47M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 57.15M |
| September 17, 2026 | 56.39M |
| September 16, 2026 | 54.86M |
| September 15, 2026 | 59.69M |
| September 14, 2026 | 62.23M |
| September 11, 2026 | 56.39M |
| September 10, 2026 | 63.50M |
| September 09, 2026 | 65.28M |
| September 08, 2026 | 63.50M |
| September 04, 2026 | 69.34M |
| September 03, 2026 | 68.33M |
| September 02, 2026 | 66.55M |
| September 01, 2026 | 63.50M |
| August 31, 2026 | 61.47M |
| August 28, 2026 | 62.48M |
| August 27, 2026 | 64.01M |
| August 26, 2026 | 66.80M |
| August 25, 2026 | 68.58M |
| August 24, 2026 | 66.80M |
| August 21, 2026 | 72.90M |
| August 20, 2026 | 67.31M |
| August 19, 2026 | 69.09M |
| August 18, 2026 | 66.55M |
| August 17, 2026 | 72.39M |
| August 14, 2026 | 71.12M |
| Date | Value |
|---|---|
| August 13, 2026 | 72.39M |
| August 12, 2026 | 71.63M |
| August 11, 2026 | 70.61M |
| August 10, 2026 | 39.78M |
| August 07, 2026 | 35.76M |
| August 06, 2026 | 35.01M |
| August 05, 2026 | 33.22M |
| August 04, 2026 | 31.88M |
| August 03, 2026 | 30.69M |
| July 31, 2026 | 29.80M |
| July 30, 2026 | 30.39M |
| July 29, 2026 | 30.84M |
| July 28, 2026 | 30.84M |
| July 27, 2026 | 31.29M |
| July 24, 2026 | 30.84M |
| July 23, 2026 | 31.14M |
| July 22, 2026 | 32.33M |
| July 21, 2026 | 31.14M |
| July 20, 2026 | 32.48M |
| July 17, 2026 | 31.73M |
| July 16, 2026 | 29.50M |
| July 15, 2026 | 29.05M |
| July 14, 2026 | 31.14M |
| July 13, 2026 | 30.54M |
| July 10, 2026 | 31.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.126B |
| Anixa Biosciences, Inc. | 93.38M |
Market Cap Related Metrics
| PEG Ratio | -0.0040 |
| Price to Book Value | 2.855 |
| Price | 2.105 |
| Earnings Yield | -89.20% |
| PEGY Ratio | -0.0040 |